GSK3B and nasopharyngeal carcinoma: In our studies, MYH9 had shown a powerful ability to promote pathogenesis of nasopharyngeal carcinoma (NPC) and hepatocellular carcinoma (HCC) via binding to GSK3β or HBV X protein (HBX).34, 35